Interest in the gut microbiota has escalated with growing appreciation of the role of indigenous microbes in the health of the host and in the pathogenesis of several intestinal and extraintestinal disorders. The microbiota has become a plausible target for drug and dietary therapy and a repository from which bioactive agents or new drugs can be mined.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effects of dietary fibers and prebiotics in adiposity regulation via modulation of gut microbiota
Applied Biological Chemistry Open Access 07 January 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
Wu, G. U. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105–108 (2011).
Shanahan, F. & Murphy, E. The hybrid science of diet, microbes, and metabolic health. Am. J. Clin. Nutr. 94, 1–2 (2011).
Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57–63 (2011).
Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228–231 (2010).
Bloom, S. M. et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9, 390–403 (2011).
Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745–757 (2011).
Round, J. L. et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974–977 (2011).
Yan, F. et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J. Clin. Invest. 121, 2242–2253 (2011).
Rea, M. C. et al. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4639–4644 (2011).
Acknowledgements
F. S. is supported, in part, by Science Foundation Ireland.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
F. Shanahan has received grant/research support from Alimentary Health Ltd, for whom he is also a stockholder/director and a patent holder/applicant. He is also a consultant for and has received grant/research support from GlaxoSmithKline and Procter & Gamble. The content of this paper was neither influenced nor constrained by that fact.
Rights and permissions
About this article
Cite this article
Shanahan, F. Translating the microbiota to medicine. Nat Rev Gastroenterol Hepatol 9, 72–74 (2012). https://doi.org/10.1038/nrgastro.2011.250
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2011.250
This article is cited by
-
Effects of dietary fibers and prebiotics in adiposity regulation via modulation of gut microbiota
Applied Biological Chemistry (2020)
-
Gut microbiota: a perspective of precision medicine in endocrine disorders
Journal of Diabetes & Metabolic Disorders (2020)
-
Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome
Neuropsychopharmacology (2017)
-
Does microbiota composition affect thyroid homeostasis?
Endocrine (2015)
-
The gut microbiota—a clinical perspective on lessons learned
Nature Reviews Gastroenterology & Hepatology (2012)
